Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Aenova Invests US$10.5 million (10 million Euros) to Enhance its Production Capacity in Italy
Aenova invests around US$105 million 10 million Euros in additional production capacity for semisolids and nonsterile liquids at their Carugate site, Italy
MD Anderson Breaks Ground on US$668 million New Research Facility in USA
The University of Texas MD Anderson Cancer Center with an investment of US$668 plans for the new cuttingedge research campus
Bigelow Laboratory Invests US$30 million to Open New Centre in Maine, USA
Bigelow Laboratory with an investment of US$30 million plans to open a new advance ocean education and innovation centre
Cleveland Clinic Plans to Construct Research Building in USA
The stateoftheart facilities will be dedicated to enhance scientific investigations and expanding laboratory research space on its main campus
MaaT Pharma and Skyepharma Construct New Manufacturing Facility in Europe
MaaT Pharma and Skyepharma have successfully completed the construction of Europes largest manufacturing facility dedicated to microbiome ecosystem therapies
Astraea Bioseparations Expands Manufacturing and Warehousing Capacity in Massachusetts, USA
Astraea Bioseparations is expanding its manufacturing and warehousing capacity to support chromatography solutions in Massachusetts, USA
Novo Nordisk Invests US$134 million (DKK 950 million) for New Cell Therapy Facility in Denmark, Europe
Novo Nordisk plans to invest US$134 million DKK 950 million to open worldclass cell facility located at Denmark, Europe
Merck Invests US$29 million (€28 million) to Open Drug Manufacturing Sites in Germany
Merck plans to invest US$29 million 28 million to open two new GMPgrade mRNA drug substance manufacturing sites in Darmstadt and Hamburg, Germany
MSD Invests US$1.18 billion (€1 billion) to Expand Footprint in Ireland
MSD invests US$118 billion 1 billion to expand its facilities in Dunboyne and Carlow, both situated in Ireland
Astellas Pharma Invests US$352 million (€330 million) in State-of-the-Art Facility in Kerry, Ireland
The stateoftheart facility is planned to span approximately 447 acres in size It will consist of a 3storey building with a total floor area of 17,000 square metres, and the buildings footprint will cover approximately 7,300 square metres
